DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Mylan Inc. (NASDAQ: MYL)

72.63 -0.05 (-0.07%)

REAL-TIME: Last trade at

Extended Hours: $72.63 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

MYL $72.63 -0.07%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $72.73
Previous Close $72.68
Daily Range $72.56 - $73.86
52-Week Range $44.80 - $76.69
Market Cap $35.6B
P/E Ratio 33.34
Dividend (Yield) $0.00 (0.0%)
Volume 7,327,921
Average Daily Volume 9,428,685
Current FY EPS $4.13

Sector

Healthcare

Industry

Drug Makers

Mylan Inc. (MYL) Description

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients. Website: http://www.mylan.com/

News & Commentary Rss Feed

Billionaire George Soros Just Sold These 3 Stocks: Should You?

The Soros Fund Management sold Kite Pharma, Valeant Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. in the first quarter. Should you follow in its footsteps?

Teva Settles Provigil Drug Delay Charge with FTC for $1.2B - Analyst Blog

Teva Settles Provigil Drug Delay Charge with FTC for $1.2B - Analyst Blog

The Love Triangle In Generic Drugs

Benzinga's M&A Chatter for Wednesday May 27, 2015

Jim Cramer -- FireEye and Other Cybersecurity Firms Are a Long-Term Play

Report: Mylan Could See Sweetened Bid From Teva Pharmaceutical

Actavis Stock - A Must Have For Long-Term Investors

3 Stocks Driving The Health Care Sector Higher

Nasdaq 100 Movers: LVNTA, MYL

Will Competition Cause Teva Pharmaceutical Industries ltd. To Tumble?

The FDA has approved Novartis' biosimilar to Teva Pharmaceuticals' Copaxone.

See More MYL News...

MYL's Top Competitors

MYL $72.63 (-0.07%)
Current stock: MYL
NVS $102.73 (-1.46%)
Current stock: NVS
PFE $34.75 (0.90%)
Current stock: PFE
JNJ $100.14 (-1.00%)
Current stock: JNJ